CMTM Family and Gastrointestinal Tract Cancers: A Comprehensive Review
Open Access
- 1 April 2022
- journal article
- review article
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 14, 1551-1563
Abstract
Gastrointestinal tract cancers are a highly heterogeneous group of malignant diseases, contributing significantly to the burden of death worldwide. Chemokine-like factor (CKLF)-like MARVEL transmembrane domain-containing family (CMTMs) plays important roles in cancer development and progression. Since the first member was cloned, there have been abundant studies on the relationships between the CMTM family and human cancers. It has been reported that the CMTM family has a large potential prognostic value for multiple cancers. Meanwhile, upregulated or downregulated expression of the family members was related to advanced tumor stage, metastasis, and overall survival. Studies have also reported that these proteins play critical roles in antitumor immunity. We performed a systematic review to sum up the latest advances of CMTM family’ roles in gastrointestinal tract cancers, with a primary focus on hepatocellular carcinoma and gastric carcinoma.Keywords
This publication has 119 references indexed in Scilit:
- Chemokine-Like Factor 1 (CLFK1) Is Over-Expressed in Patients with Atopic DermatitisInternational Journal of Biological Sciences, 2013
- Down-regulation of CMTM8 Induces Epithelial-to-Mesenchymal Transition-like Changes via c-MET/Extracellular Signal-regulated Kinase (ERK) SignalingJournal of Biological Chemistry, 2012
- Pancreatic CancerNew England Journal of Medicine, 2010
- Identification and Characterization of CMTM4, a Novel Gene with Inhibitory Effects on HeLa Cell Growth through Inducing G2/M Phase AccumulationMolecules and Cells, 2010
- CMTM5 induces apoptosis of pancreatic cancer cells and has synergistic effects with TNF-αBiochemical and Biophysical Research Communications, 2009
- CMTM5-v1 induces apoptosis in cervical carcinoma cellsBiochemical and Biophysical Research Communications, 2009
- The preclinical activity of the histone deacetylase inhibitor PXD101 (belinostat) in hepatocellular carcinoma cell linesInvestigational New Drugs, 2009
- CMTM5 Exhibits Tumor Suppressor Activities and Is Frequently Silenced by Methylation in Carcinoma Cell LinesClinical Cancer Research, 2007
- Expression of chemokine-like factor 1 is upregulated during T lymphocyte activationLife Sciences, 2006
- Identification of eight genes encoding chemokine-like factor superfamily members 1–8 (CKLFSF1–8) by in silico cloning and experimental validationGenomics, 2003